Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
COSTS AND EXPENSES:        
Research and development $ 4,075 $ 944 $ 7,625 $ 1,685
General and administrative 1,974 1,142 3,593 2,402
Total operating expenses 6,049 2,086 11,218 4,087
Operating Loss (6,049) (2,086) (11,218) (4,087)
Interest and other financing costs, net 5 0 10 0
NET LOSS $ (6,044) $ (2,086) $ (11,208) $ (4,087)
Net loss per common share, basic and diluted (in dollars per share) $ (0.61) $ (0.95) $ (1.20) $ (1.88)
Weighted average common shares outstanding, basic and diluted (in shares) 9,923,184 2,186,537 9,324,020 2,172,921